Abstract

BackgroundAntenatal depression and antenatal anxiety adversely affect several obstetric and foetal outcomes, and increase the rate of postnatal mental illness. Thus, to tackle these challenges the need for social support during pregnancy is vital. However, an extensive literature search failed to show a published study on the relationship between domains of social support and antenatal depressive, as well as antenatal anxiety symptoms in Australia. This study examined the association between domains of social support and antenatal depressive and anxiety symptoms among Australian women.MethodsThe current study used data obtained from the 1973–78 cohort of the Australian Longitudinal Study on Women’s Health (ALSWH), focusing upon women who reported being pregnant (n = 493). Depression and anxiety were assessed using the 10 item Center for Epidemiological Studies Depression (CES-D-10) scale, and the 9-item Goldberg Anxiety and Depression scale (GADS) respectively. The 19 item-Medical Outcomes Study Social Support index (MOSS) was used to assess social support. A logistic regression model was used to examine the associations between domains of social support and antenatal depressive and anxiety symptoms after adjusting for potential confounders.ResultThe current study found 24.7 and 20.9% of pregnant women screened positive for depressive and anxiety symptoms respectively. After adjusting for potential confounders, our study found that the odds of antenatal depressive symptoms was about four and threefold higher among pregnant women who reported low emotional/informational support (AOR = 4.75; 95% CI: 1.45, 15.66; p = 0.010) and low social support (overall support) (AOR = 3.26; 95%CI: 1.05, 10.10, p = 0.040) respectively compared with their counterpart. In addition, the odds of antenatal anxiety symptoms was seven times higher among pregnant women who reported low affectionate support/positive social interaction (AOR = 7.43; 95%CI: 1.75, 31.55; p = 0.006).ConclusionA considerable proportion of pregnant Australian women had depressive symptoms and/or anxiety symptoms, which poses serious health concerns. Low emotional/informational support and low affectionate support/positive social interaction have a significant association with antenatal depressive and anxiety symptoms respectively. As such, targeted screening of expectant women for social support is essential.

Highlights

  • MethodsThe current study used data obtained from the 1973–78 cohort of the Australian Longitudinal Study on Women’s Health (ALSWH), focusing upon women who reported being pregnant (n = 493)

  • Antenatal depression and antenatal anxiety adversely affect several obstetric and foetal outcomes, and increase the rate of postnatal mental illness

  • After adjusting for potential confounders, the multiple logistic regression model found that the odds of antenatal depressive symptoms was fourfold higher among pregnant women who reported low emotional/ informational support (AOR = 4.75; 95% CI: 1.45, 15.66; p = 0.010) compared with pregnant women who reported high emotional/informational support

Read more

Summary

Methods

Population and sampling The current study employed a community based crosssectional study design and reported per the guideline of the STROBE checklist (Additional file 1). The Medical Outcomes Study Social Support index (MOSS) was used to examine the functional support provided, with good reliability (α = 0.97) and validity [56, 57] and used among Australian women [58]. The consumption of alcohol among study participants was assessed using the National Health and Medical Research Council (NHMRC) guidelines and categorized as: low-risk drinker; non-drinker; rarely drinks; risky/ high-risk drinker [63]. Study participants were asked if they used any of the following illicit drugs in the past 12-month; Marijuana; Amphetamines; LSD; Hallucinogens; Tranquillizers; Cocaine; Ecstasy/designer drugs; Inhalants; Heroin; Barbiturates; and Steroids Based on their responses, the women were classified as being either a “non-user” or a “user” of an illicit drug. The E-value is the minimum strength of association on the odds ratio estimate that an unmeasured confounder possibly will require to have with both the exposure and outcome to negate the reported associations based on measured confounders [67, 68]

Result
Conclusion
Background
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call